These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25874797)

  • 41. The GERD market.
    Ashburn TT; Gupta MS
    Nat Rev Drug Discov; 2006 Apr; 5(4):277-8. PubMed ID: 16628833
    [No Abstract]   [Full Text] [Related]  

  • 42. Rheumatoid nodules and reflux disease.
    Beaver ME; Stasney CR; Rodriguez M
    Ear Nose Throat J; 2004 May; 83(5):309. PubMed ID: 15195871
    [No Abstract]   [Full Text] [Related]  

  • 43. Medical therapy for gastroesophageal reflux disease.
    Arora AS; Castell DO
    Mayo Clin Proc; 2001 Jan; 76(1):102-6. PubMed ID: 11155401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease.
    Richter JE
    Am J Med; 2003 Aug; 115 Suppl 3A():179S-187S. PubMed ID: 12928099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New pharmacologic approaches in gastroesophageal reflux disease.
    Armstrong D; Sifrim D
    Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: "for whom the bell tolls".
    Fennerty MB; Lieberman D
    Gastroenterology; 1994 Nov; 107(5):1545-8. PubMed ID: 7926519
    [No Abstract]   [Full Text] [Related]  

  • 47. Reflux-associated laryngitis and laryngopharyngeal reflux: a gastroenterologist's point of view.
    Hammer HF
    Dig Dis; 2009; 27(1):14-7. PubMed ID: 19439955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastroesophageal reflux disease. The long and the short of therapeutic options.
    Brady WM; Ogorek CP
    Postgrad Med; 1996 Nov; 100(5):76-80, 85-6, 89. PubMed ID: 8917326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Something's burning.
    Hensrud DD
    Fortune; 2002 Jul; 146(1):150. PubMed ID: 12119728
    [No Abstract]   [Full Text] [Related]  

  • 50. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [What are the results of medical treatments?].
    Chassany O; Douet MC; Ducrot F
    Rev Med Brux; 1999 Apr; 20(2):A115-6. PubMed ID: 10335110
    [No Abstract]   [Full Text] [Related]  

  • 53. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soothing the burn. Management of gastroesophageal reflux disease.
    Kempf WI
    Adv Nurse Pract; 2004 Jan; 12(1):47-50. PubMed ID: 14730836
    [No Abstract]   [Full Text] [Related]  

  • 57. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 58. [The influence of gastroesophageal reflux on the course and therapy of bronchial asthma].
    Samoliński B
    Pol Merkur Lekarski; 2006 Oct; 21(124):307-9. PubMed ID: 17205765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC
    Am J Manag Care; 2000 Aug; 6(8):934-5. PubMed ID: 11186505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.